litlas
Log inCreate account

Francesco Passamonti

Active 1999–2025

181
Papers
34,252
Citations
90
h-index
171
i10-index

Citations

Citations per year for Francesco Passamonti2001: 5 citations2002: 3 citations2003: 5 citations2004: 5 citations2005: 56 citations2006: 97 citations2007: 122 citations2008: 142 citations2009: 144 citations2010: 152 citations2011: 197 citations2012: 257 citations2013: 271 citations2014: 259 citations2015: 305 citations2016: 242 citations2017: 209 citations2018: 214 citations2019: 680 citations2020: 1,044 citations2021: 926 citations2022: 920 citations2023: 793 citations2024: 1,461 citations2025: 503 citations2026: 7 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,939 citing papers, 22.9% of this breakdownItaly: 904 citing papers, 10.7% of this breakdownGermany: 652 citing papers, 7.7% of this breakdownUnited Kingdom: 607 citing papers, 7.2% of this breakdownFrance: 559 citing papers, 6.6% of this breakdownSpain: 399 citing papers, 4.7% of this breakdownChina: 250 citing papers, 3% of this breakdownCanada: 247 citing papers, 2.9% of this breakdownSwitzerland: 237 citing papers, 2.8% of this breakdownNetherlands: 212 citing papers, 2.5% of this breakdownAustria: 190 citing papers, 2.2% of this breakdownSweden: 183 citing papers, 2.2% of this breakdown
0%22.9%Other 24.6%

Institutions

Fields

  • Medicine90.3%
  • Biochemistry, Genetics and Molecular Biology5.9%
  • Immunology and Microbiology2.6%
  • Computer Science0.3%
  • Chemistry0.2%
  • Psychology0.1%
  • Other0.6%

Topics

  • Myeloproliferative Neoplasms: Diagnosis and Treatment18.2%
  • Acute Myeloid Leukemia Research13.2%
  • Chronic Myeloid Leukemia Treatments6.1%
  • Kruppel-like factors research5.9%
  • Eosinophilic Disorders and Syndromes5.6%
  • Cytokine Signaling Pathways and Interactions2.5%
  • Other48.5%

Coauthors

All papers

Open in search
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Authors: Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström‐Lindberg, Gabriela Hobbs, Ronald Hoffman, Elias Jabbour, Jean‐Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 cited by 2,693

  2. A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

    Authors: Róbert Královics, Francesco Passamonti, Andreas Buser, Soon-Siong Teo, Ralph Tiedt, Jakob Passweg, André Tichelli, Mario Cazzola, Radek C. Skoda - New England Journal of Medicine 2005 cited by 3,459

  3. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

    Authors: Srđan Verstovšek, Aaron T. Gerds, Alessandro M. Vannucchi, Haifa Kathrin Al‐Ali, David Lavie, Andrew Kuykendall, Sebastian Grosicki, Alessandra Iurlo, Yeow Tee Goh, Mihaela Lazaroiu, Miklós Egyed, María Laura Fox, Donal P. McLornan, Andrew C. Perkins, Sung‐Soo Yoon, Vikas Gupta, Jean‐Jacques Kiladjian, Nikki Granacher, Sung‐Eun Lee, Luminita Ocroteala, Francesco Passamonti, Claire Harrison, Barbara Klencke, Sunhee Ro, Rafe Donahue, Jun Kawashima, Ruben A. Mesa, Adi Shacham Abulafia, Haifa Kathrin Al‐Ali, Björn Andréasson, Anna Angona, Rosa Ayala, Soo‐Mee Bang, Bruce Bank, Fiorenza Barraco, Eloise Beggiato, Fleur Samantha Benghiat, Massimiliano Bonifacio, Claire Bories, Gabriela Borsaru, Mette Brabrand, Andrei Braester, Andes Broliden, Veronika Buxhofer‐Ausch, Nathalie Cambier, Marianna Caramella, Benjamin Carpentier, Nicola Cascavilla, Maria Giraldo Castellano, Hung Chang, Chih‐Cheng Chen, June‐Won Cheong, Yunsuk Choi, Philip Choi, Maria Teresa Corsetti, Isabel Montero Cuadrado, Julia Cunningham, Gandhi Damaj, Valerio De Stefano, Robert Delage, Regina Garcĺa Delgado, José Miguel Torregrosa Diaz, Péter Dombi, Viviane Dubruille, Miklós Egyed, Daniel El Fassi, Anna Elinder-Camburn, Elena Maria Elli, Martin Ellis, Carmen Fava, Salman Fazal, Angela Fleischman, Lynda Foltz, María Laura Fox, Nashat Gabrail, Jose Valentĺn Garcĺa-Gutiérrez, Aaron T. Gerds, Stéphane Girault, Heinz Gisslinger, Alexandru Gluvacov, Yeow Tee Goh, Joachim R. Göthert, Nikki Granacher, Sebastian Grosicki, Vikas Gupta, Evgeni Hadjiev, Kaoutar Hafraoui, Aryan Hamed, Claire Harrison, Hans Carl Hasselbalch, Hanns Hauser, Mark Heaney, Holger Hebart, Jesús María Hernández‐Rivas, Victor Higuero Saavedra, Christopher Hillis, Hsin‐An Hou, Jonathan P. How, Daniel Huang, Marek Hus and 95 more - The Lancet 2023 cited by 185

  4. MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis

    Authors: Paola Guglielmelli, Terra L. Lasho, Giada Rotunno, Mythri Mudireddy, Carmela Mannarelli, Maura Nicolosi, Annalisa Pacilli, Animesh Pardanani, Elisa Rumi, Vittorio Rosti, Curtis A. Hanson, Francesco Mannelli, Rhett P. Ketterling, Naseema Gangat, Alessandro Rambaldi, Francesco Passamonti, Giovanni Barosi, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi, Ayalew Tefferi - Journal of Clinical Oncology 2017 cited by 532

  5. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

    Authors: Animesh Pardanani, Claire Harrison, Jörge E. Cortes, Francisco Cervantes, Ruben A. Mesa, Donald Milligan, Tamás Masszi, Elena Mishchenko, Éric Jourdan, Alessandro M. Vannucchi, Mark W. Drummond, Mindaugas Jurgutis, Kazimierz Kuliczkowski, Emanuil Gheorghita, Francesco Passamonti, Frank Neumann, Abhay Patki, Guozhi Gao, Ayalew Tefferi - JAMA Oncology 2015 cited by 472

  6. A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

    Authors: Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi, Enrica Morra, Elisa Rumi, Arturo Pereira, Paola Guglielmelli, Ester Pungolino, Marianna Caramella, Margherita Maffioli, Cristiana Pascutto, Mario Lazzarino, Mario Cazzola, Ayalew Tefferi - Blood 2009 cited by 968

  7. DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

    Authors: Naseema Gangat, Domenica Caramazza, Rakhee Vaidya, Geeta George, Kebede H. Begna, Susan M. Schwager, Daniel Van Dyke, Curtis A. Hanson, Wenting Wu, Animesh Pardanani, Francisco Cervantes, Francesco Passamonti, Ayalew Tefferi - Journal of Clinical Oncology 2010 cited by 1,032

  8. Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    Authors: Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer, Tamás Masszi, Simon Durrant, Francesco Passamonti, Claire Harrison, Fabrizio Pane, Pierre Zachée, Ruben A. Mesa, Shui He, Mark M. Jones, William M. Garrett, Jingjin Li, Ulrich Pirron, Dany Habr, Srđan Verstovšek - New England Journal of Medicine 2015 cited by 872

  9. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

    Authors: Tiziano Barbui, Ayalew Tefferi, Alessandro M. Vannucchi, Francesco Passamonti, Richard T. Silver, Ronald Hoffman, Srđan Verstovšek, Ruben A. Mesa, Jean‐Jacques Kiladjian, Rȕdiger Hehlmann, Andreas Reiter, Francisco Cervantes, Claire Harrison, Mary Frances Mc Mullin, Hans Carl Hasselbalch, Steffen Koschmieder, Monia Marchetti, Andrea Bacigalupo, Guido Finazzi, Nicolaus Kröger, Martin Grießhammer, Gunnar Birgegård, Giovanni Barosi - Leukemia 2018 cited by 552

  10. Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial

    Authors: Claire Harrison, Alessandro M. Vannucchi, Uwe Platzbecker, Francisco Cervantes, Vikas Gupta, David Lavie, Francesco Passamonti, Elliott F. Winton, Hua Dong, Jun Kawashima, Julia D. Maltzman, Jean‐Jacques Kiladjian, Srđan Verstovšek - The Lancet Haematology 2017 cited by 315

  11. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment

    Authors: Francisco Cervantes, Brigitte Dupriez, Arturo Pereira, Francesco Passamonti, John T. Reilly, Enrica Morra, Alessandro M. Vannucchi, Ruben A. Mesa, Jean‐Loup Demory, Giovanni Barosi, Elisa Rumi, Ayalew Tefferi - Blood 2008 cited by 1,237

  12. Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report

    Authors: Ayalew Tefferi, Francisco Cervantes, Ruben A. Mesa, Francesco Passamonti, Srđan Verstovšek, Alessandro M. Vannucchi, Jason Gotlib, Brigitte Dupriez, Animesh Pardanani, Claire Harrison, Ronald Hoffman, Heinz Gisslinger, Nicolaus Kröger, Jüergen Thiele, Tiziano Barbui, Giovanni Barosi - Blood 2013 cited by 379

  13. Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

    Authors: Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Ramón V. Tiu, Pierre Zachée, Éric Jourdan, Elliott F. Winton, Richard T. Silver, Harry C. Schouten, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Joanne Lager, Zhenming Shun, Ruben A. Mesa - The Lancet Haematology 2017 cited by 330

  14. Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)

    Authors: Tiziano Barbui, Guido Finazzi, Alessandra Carobbio, Jüergen Thiele, Francesco Passamonti, Elisa Rumi, Marco Ruggeri, Francesco Rodeghiero, Maria Luigia Randi, Irene Bertozzi, Heinz Gisslinger, Veronika Buxhofer‐Ausch, Valerio De Stefano, Silvia Betti, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi - Blood 2012 cited by 589

  15. A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis

    Authors: Francesco Passamonti, Toni Giorgino, Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami S. Komrokji, Jason Gotlib, Jean‐Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T. Silver, Giulia Benevolo, Francesco Albano, Domenica Caramazza, Michele Merli, Daniela Pietra, Rosario Casalone, Giada Rotunno, Tiziano Barbui, Mario Cazzola, Alessandro M. Vannucchi - Leukemia 2017 cited by 334

  16. A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis

    Authors: Margherita Maffioli, Barbara Mora, Somedeb Ball, Alessandra Iurlo, Elena Maria Elli, Maria Chiara Finazzi, Nicola Polverelli, Elisa Rumi, Marianna Caramella, Maria Cristina Carraro, Mariella D’Adda, Alfredo Molteni, Cinzia Sissa, Francesca Lunghi, Alessandro Vismara, Marta Ubezio, Anna Guidetti, Sabrina Caberlon, Michela Anghilieri, Rami S. Komrokji, Daniele Cattaneo, Matteo Giovanni Della Porta, Toni Giorgino, Lorenza Bertù, Marco Brociner, Andrew Kuykendall, Francesco Passamonti - Blood Advances 2022 cited by 116

  17. Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group

    Authors: Nicolaus Kröger, Andrea Bacigalupo, Tiziano Barbui, Markus Ditschkowski, Nico Gagelmann, Martin Grießhammer, Vikas Gupta, Nada Hamad, Claire Harrison, Juan Carlos Hernández‐Boluda, Steffen Koschmieder, Tania Jain, John Mascarenhas, Ruben A. Mesa, Uday Popat, Francesco Passamonti, Nicola Polverelli, Alessandro Rambaldi, Marie Robin, Rachel B. Salit, Thomas Schroeder, Bart L. Scott, Roni Tamari, Ayalew Tefferi, Alessandro M. Vannucchi, Donal P. McLornan, Giovanni Barosi - The Lancet Haematology 2023 cited by 96

  18. Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    Authors: Robyn M. Emanuel, Amylou C. Dueck, Holly L. Geyer, Jean‐Jacques Kiladjian, Stefanie Slot, Sonja Zweegman, Peter A.W. te Boekhorst, Suzan Commandeur, Harry C. Schouten, Federico Sackmann, Ana Kerguelen Fuentes, Dolores Hernández‐Maraver, Heike L. Pahl, Martin Grießhammer, Frank Stegelmann, Konstanze Doehner, Thomas Lehmann, Karin Bonatz, Andreas Reiter, Françoise Boyer, Gabriel Étienne, Jean‐Christophe Ianotto, Dana Ranta, Lydia Roy, Jean‐Yves Cahn, Claire Harrison, Deepti Radia, Pablo Muxí, Norman Maldonado, Carlos Besses, Francisco Cervantes, Peter Johansson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Björn Andréasson, Maria L Ferarri, Alessandro Rambaldi, Jan Samuelsson, Gunnar Birgegård, Ayalew Tefferi, Ruben A. Mesa - Journal of Clinical Oncology 2012 cited by 458

  19. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study

    Authors: Ayalew Tefferi, Elisa Rumi, Guido Finazzi, Heinz Gisslinger, Alessandro M. Vannucchi, Francesco Rodeghiero, Maria Luigia Randi, Rakhee Vaidya, Mario Cazzola, Alessandro Rambaldi, Bettina Gisslinger, Lisa Pieri, Marco Ruggeri, Irene Bertozzi, Nanna Sulai, Ilaria Carola Casetti, Alessandra Carobbio, Georg Jeryczynski, Dirk R. Larson, Leonhard Müllauer, Animesh Pardanani, J. Thiele, Francesco Passamonti, Tiziano Barbui - Leukemia 2013 cited by 677

  20. MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis

    Authors: John Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, Francesca Palandri, Timothy Devos, Francesco Passamonti, Raajit K. Rampal, Adam J. Mead, Gabriella Hobbs, Joseph M. Scandura, Moshe Talpaz, Nikki Granacher, Tim C. P. Somervaille, Ronald Hoffman, Mariëlle J. Wondergem, Mohamed E. Salama, Gozde Colak, Jike Cui, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, Srđan Verstovšek, Natalia Curto‐García, Claire Harrison, Vikas Gupta - Journal of Clinical Oncology 2023 cited by 85

  21. Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

    Authors: Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Tommaso Matteuzzi, Claudia Sala, Ettore Mosca, Chiara Chiereghin, Noemi Di Nanni, Matteo Gnocchi, Matteo Zampini, Marianna Rossi, Giulia Maggioni, Alberto Termanini, Emanuele Angelucci, Massimo Bernardi, Lorenza Borin, Benedetto Bruno, Francesca Bonifazi, Valeria Santini, Andrea Bacigalupo, Maria Teresa Voso, Esther Natalie Olíva, Marta Riva, Marta Ubezio, Lucio Morabito, Alessia Campagna, Claudia Saitta, Victor Savevski, Enrico Giampieri, Daniel Remondini, Francesco Passamonti, Fabio Ciceri, Niccolò Bolli, Alessandro Rambaldi, Wolfgang Kern, Shahram Kordasti, Françesc Solé, Laura Palomo, Guillermo Sanz, Armando Santoro, Uwe Platzbecker, Pierre Fenaux, Luciano Milanesi, Torsten Haferlach, Gastone Castellani, Matteo Giovanni Della Porta - Journal of Clinical Oncology 2021 cited by 225

  22. Myelofibrosis

    Authors: Francesco Passamonti, Barbara Mora - Blood 2022 cited by 132

  23. Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations

    Authors: Monia Marchetti, Alessandro Maria Vannucchi, Martin Griesshammer, Claire Harrison, Steffen Koschmieder, Heinz Gisslinger, Alberto Álvarez-Larrán, Valerio De Stefano, Paola Guglielmelli, Francesca Palandri, Francesco Passamonti, Giovanni Barosi, Richard T Silver, Rüdiger Hehlmann, Jean-Jacques Kiladjian, Tiziano Barbui - The Lancet Haematology 2022 cited by 113

  24. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

    Authors: Livio Pagano, Jon Salmanton‐García, Francesco Marchesi, Alessandro Busca, Paolo Corradini, Martin Hoenigl, Н Н Климко, Philipp Koehler, Antonio Pagliuca, Francesco Passamonti, Luisa Verga, Benjamín Víšek, Osman İlhan, Gianpaolo Nadali, Barbora Weinbergerová, Raúl Córdoba, Monia Marchetti, Graham P. Collins, Francesca Farina, Chiara Cattaneo, Alba Cabirta, María Gomes da Silva, Federico Itri, Jaap A. van Doesum, Marie‐Pierre Ledoux, Martin Čerňan, Ozren Jakšić, Rafael F. Duarte, Gabriele Magliano, Ali S. Omrani, Nicola Fracchiolla, Austin Kulasekararaj, Toni Valković, Christian Bjørn Poulsen, Marina Machado, Andreas Glenthøj, И. О. Стома, Zdeněk Ráčil, Klára Piukovics, Milan Navrátil, Ziad Emarah, Uluhan Sili, Johan Maertens, Ola Blennow, Rui Bergantim, Carolina García‐Vidal, Lucia Prezioso, Anna Guidetti, Maria Ilaria Del Principe, Marina Popova, Nick de Jonge, Irati Ormazabal‐Vélez, Noemí Fernández, Iker Falces‐Romero, Annarosa Cuccaro, Stef Meers, Caterina Buquicchio, Darko Antić, Murtadha Al‐Khabori, Ramón García‐Sánz, Monika Biernat, Maria Chiara Tisi, Ertan Sal, Laman Rahimli, Nataša Čolović, Martin Schönlein, María Calbacho, Carlo Tascini, Carolina Miranda, Nina Khanna, Gustavo‐Adolfo Méndez, Verena Petzer, Jan Novák, Caroline Besson, Rémy Duléry, Sylvain Lamure, Márcio Nucci, Giovanni Paolo Maria Zambrotta, Павел Зак, Güldane Cengiz Seval, Valentina Bonuomo, Jiřı́ Mayer, Alberto López‐García, Maria Vittoria Sacchi, Stephen Booth, Fabio Ciceri, Margherita Oberti, Marco Salvini, Macarena Izuzquiza, Raquel Nunes Rodrigues, Emanuele Ammatuna, Aleš Obr, Raoul Herbrecht, Lucía Núñez-Martín-Buitrago, Valentina Mancini, Hawraa Shwaylia, Mariarita Sciumé, Jenna Essame, Marietta Nygaard, Josip Batinić and 96 more - Journal of Hematology & Oncology 2021 cited by 318